Technical Analysis for KRYS - Krystal Biotech, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical KRYS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 1.42% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 1.42% | |
| Volume Surge | Other | 1.42% | |
| Inside Day | Range Contraction | 1.42% | |
| Wide Bands | Range Expansion | 1.42% | |
| Crossed Above 20 DMA | Bullish | 0.03% | |
| Crossed Above 50 DMA | Bullish | 0.03% | |
| MACD Bullish Signal Line Cross | Bullish | 0.03% | |
| New Uptrend | Bullish | 0.03% | |
| Pocket Pivot | Bullish Swing Setup | 0.03% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Biotechnology
Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.
Medicine Rare Diseases Gene Therapy Medical Genetics Genetic Genealogy Genodermatoses Herpes Simplex Virus Epidermolysis Bullosa Itchiness Netherton Syndrome
Medicine Rare Diseases Gene Therapy Medical Genetics Genetic Genealogy Genodermatoses Herpes Simplex Virus Epidermolysis Bullosa Itchiness Netherton Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 66.5 |
| 52 Week Low | 18.5 |
| Average Volume | 179,199 |
| 200-Day Moving Average | 43.29 |
| 50-Day Moving Average | 56.27 |
| 20-Day Moving Average | 54.73 |
| 10-Day Moving Average | 51.63 |
| Average True Range | 3.85 |
| ADX | 24.0 |
| +DI | 22.51 |
| -DI | 20.60 |
| Chandelier Exit (Long, 3 ATRs ) | 51.89 |
| Chandelier Exit (Short, 3 ATRs ) | 56.77 |
| Upper Bollinger Band | 63.60 |
| Lower Bollinger Band | 45.86 |
| Percent B (%b) | 0.57 |
| BandWidth | 32.42 |
| MACD Line | -0.90 |
| MACD Signal Line | -1.21 |
| MACD Histogram | 0.3098 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 59.55 | ||||
| Resistance 3 (R3) | 59.60 | 58.47 | 58.97 | ||
| Resistance 2 (R2) | 58.47 | 57.58 | 58.45 | 58.77 | |
| Resistance 1 (R1) | 57.25 | 57.02 | 56.69 | 57.20 | 58.57 |
| Pivot Point | 56.13 | 56.13 | 55.84 | 56.10 | 56.13 |
| Support 1 (S1) | 54.90 | 55.23 | 54.34 | 54.86 | 53.49 |
| Support 2 (S2) | 53.78 | 54.67 | 53.75 | 53.29 | |
| Support 3 (S3) | 52.56 | 53.78 | 53.09 | ||
| Support 4 (S4) | 52.51 |
